Literature DB >> 7631957

Visceral antinociceptive effects of spinal clonidine combined with morphine, [D-Pen2, D-Pen5] enkephalin, or U50,488H.

Y Harada1, K Nishioka, L M Kitahata, K Kishikawa, J G Collins.   

Abstract

BACKGROUND: Visceral pain is an important component of many clinical pain states. The perispinal administration of drug combinations rather than a single agent may reduce side effects while maximizing analgesic effectiveness. The purpose of this study was to examine the nature of interactions between an alpha 2-adrenergic agonist (clonidine) and a mu-opioid agonist (morphine), a delta-opioid agonist ([D-Pen2, D-Pen5] enkephalin [DPDPE]), or a kappa-opioid agonist (U50,488H).
METHODS: Colorectal distension was used to elicit a nociceptive visceromotor response (contraction of abdominal musculature) in rats. The ability of intrathecally administered clonidine alone or in combination with morphine, DPDPE, or U50,488H to alter thresholds for the production of the visceromotor response was examined.
RESULTS: Clonidine produced dose-dependent reduction in threshold. U50,488H, at the doses tested, showed no synergistic interaction with clonidine.
CONCLUSIONS: Spinal combinations of alpha 2-adrenergic and mu- or delta- but not kappa-opioid agonists may be beneficial in the control of visceral pain.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7631957     DOI: 10.1097/00000542-199508000-00015

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  18 in total

1.  Effects of yohimbine on the antinociceptive and place conditioning effects of opioid agonists in rodents.

Authors:  L Morales; C Perez-Garcia; L F Alguacil
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  Effect of different doses of dexmedetomidine as adjuvant in bupivacaine -induced subarachnoid block for traumatized lower limb orthopaedic surgery: a prospective, double-blinded and randomized controlled study.

Authors:  Susanta Halder; Anjan Das; Debabrata Mandal; Mainak Chandra; Souradeep Ray; Madhuri Ranjana Biswas; Parthojit Mandal; Tanuka Das
Journal:  J Clin Diagn Res       Date:  2014-11-20

3.  Effect of Two Different Doses of Dexmedetomidine as Adjuvant in Bupivacaine Induced Subarachnoid Block for Elective Abdominal Hysterectomy Operations: A Prospective, Double-blind, Randomized Controlled Study.

Authors:  Anjan Das; Susanta Halder; Surajit Chattopadhyay; Parthajit Mandal; Subinay Chhaule; Rezina Banu
Journal:  Oman Med J       Date:  2015-07

4.  Dexmedetomidine as an intrathecal adjuvant for postoperative analgesia.

Authors:  Rajni Gupta; Jaishri Bogra; Reetu Verma; Monica Kohli; Jitendra Kumar Kushwaha; Sanjiv Kumar
Journal:  Indian J Anaesth       Date:  2011-07

5.  A Comparative study of intrathecal dexmedetomidine and fentanyl as adjuvants to Bupivacaine.

Authors:  Rajni Gupta; Reetu Verma; Jaishri Bogra; Monica Kohli; Rajesh Raman; Jitendra Kumar Kushwaha
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-07

6.  Addition of intrathecal fentanyl to bupivacaine clonidine mixture effect on quality of subarachnoid block and postoperative analgesia.

Authors:  Marilyn Nazareth; Pabitra Ghoshal; Viraj Namshikar; Yogesh Gaude
Journal:  Anesth Essays Res       Date:  2013 Jan-Apr

7.  Dose-dependent effect of intrathecal dexmedetomidine on isobaric ropivacaine in spinal anesthesia for abdominal hysterectomy: Effect on block characteristics and hemodynamics.

Authors:  Udita Naithani; Mahendra Singh Meena; Sunanda Gupta; Khemraj Meena; Lalatendu Swain; D S Pradeep
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2015 Jan-Mar

8.  A comparative study between intrathecal dexmedetomidine and fentanyl as adjuvant to intrathecal bupivacaine in lower abdominal surgeries: A randomized trial.

Authors:  Aamir Laique Khan; Raj Bahadur Singh; Rajni K Tripathi; Sanjay Choubey
Journal:  Anesth Essays Res       Date:  2015 May-Aug

Review 9.  The Useage of Opioids and their Adverse Effects in Gastrointestinal Practice: A Review.

Authors:  MahmoudReza Khansari; MasourReza Sohrabi; Farhad Zamani
Journal:  Middle East J Dig Dis       Date:  2013-01

Review 10.  DA-9701: A New Multi-Acting Drug for the Treatment of Functional Dyspepsia.

Authors:  Yong Sam Kwon; Miwon Son
Journal:  Biomol Ther (Seoul)       Date:  2013-05-30       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.